ग्लूकागॉन और रेगुलर इंसुलिन (ह्यूमन) का इंटरैक्शन

Hypoglycemia in Patients with Insulinoma: In patients with insulinoma, administration may produce an initial increase in blood glucose; however, glucagon may stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia.

Hypoglycemia in Patients with Insulinoma In patients with insulinoma, administration of glucagon may produce an initial increase in blood glucose; however, glucagon administration may directly or indirectly (through an initial rise in blood glucose) stimulate exaggerated insulin release from an insulinoma and cause hypoglycemia.

Intervention Monitor blood glucose when GVOKE VialDx is used as a diagnostic aid in patients receiving insulin.

Insulin: Monitor blood glucose when GVOKE VialDx is used as a diagnostic aid in patients receiving insulin.

Insulin Clincial Impact: Insulin acts antagonistically to glucagon.

Atypical Antipsychotics (e.g., olanzapine and clozapine), Corticosteroids, Danazol, Diuretics, Estrogens, Glucagon, Isoniazid, Niacin, Oral Contraceptives, Phenothiazines, Progestogens (e.g., in oral contraceptives), Protease inhibitors, Somatropin, Sympathomimetic Agents (e.g., albuterol, epinephrine, terbutaline) and Thyroid Hormones.